By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Kadmon Corporation (Formerly Known As Kadmon Pharmaceuticals) 

Alexandria Center for Life Sciences
450 East 29th Street, 5th Floor
New York  New York  10016  U.S.A.
Phone: 212-308-6000 Fax: n/a




Company News
Kadmon Provides Business Update And Reports First Quarter 2017 Financial Results 5/15/2017 8:22:55 AM
Kadmon To Present Clinical And Preclinical Data Highlighting The Role Of ROCK2 Signaling In Immune System Function At AAI Annual Meeting 5/11/2017 8:15:16 AM
Kadmon Announces Publication Of Clinical Data Showing KD025 Improved Clinical Scores In Psoriasis Patients 4/12/2017 11:46:22 AM
Kadmon Submits Second Abbreviated New Drug Application Filing For Trientine Hydrochloride To FDA 4/4/2017 7:55:33 AM
Kadmon Announces Amendment To Credit Agreement And Related Warrants 4/3/2017 8:09:37 AM
Kadmon Presents Preclinical Data Supporting The Therapeutic Potential Of ROCK Inhibition In Pulmonary Fibrosis 3/28/2017 8:40:20 AM
Kadmon Reports Upcoming Milestones And Fourth Quarter And Full Year 2016 Financial Results 3/23/2017 6:53:16 AM
Kadmon Announces Approximately $23 Million Equity Financing 3/8/2017 7:55:25 AM
Kadmon Submits Abbreviated New Drug Application Filing For Trientine Hydrochloride To FDA 12/6/2016 11:35:35 AM
Kadmon Presents Encouraging Data On Tesevatinib In EGFR-Mutated Non-Small Cell Lung Cancer With Brain Metastases And/Or Leptomeningeal Metastases 12/6/2016 8:49:37 AM